Comparative analysis reveals poor tolerability of nonspecific preventives in patients with migraine, suggesting early use of erenumab can reduce burden.
Patients with migraine often cycle through multiple nonspecific preventive medications due to poor tolerability and/or inadequate efficacy leading to low adherence and increased disease burden.
No takes yet. Share an insight, caveat, or question.
Pozo‐Rosich et al. (2024) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: